India, June 1 -- This milestone is a direct result of Probi's strategic partnership with Nomura Dairy Products, a pioneer in Japan's fermented food sector

Probi, part of Symrise Group, has reached a major scientific and commercial milestone with the first-ever clinical study of its flagship probiotic strain LP299V in Japanese adults. The study sets a new benchmark for validated probiotic solutions in one of the world's most advanced functional food markets.

The randomised, double-blind, placebo-controlled study, led by Yamakawa et al and titled "Effects of Lactiplantibacillus plantarum 299v on bowel movements in healthy adults with a tendency for loose stools: a randomised, placebo-controlled, double-blind, parallel-group comparison st...